Foley Todd

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Foley Todd
CIK #0001473930
EDGAR Form CIK 2011 - 2026
3 [0001473930]
4 [0001473930]
5 [0001473930]
Form 3/4/5 Subject 2011 - 2026
Aktis Oncology Inc
Foley Todd
MPM BioVentures 2014 LP
MPM BioVentures 2014 GP LLC
iTeos Therapeutics Inc
MPM BioVentures 2018 B LP
Evnin Luke
MPM Asset Management Investors BV2014 LLC
MPM BioVentures 2014 LLC
MPM Asset Management Investors BV2018 LLC
MPM BioVentures 2014 B LP
Werewolf Therapeutics Inc
Entrada Therapeutics Inc
Gadicke Ansbert
Repare Therapeutics Inc
TCR2 Therapeutics Inc
MPM Asset Management LLC
Chiasma Inc
Harpoon Therapeutics Inc
Rhythm Pharmaceuticals Inc
Turmeric Acquisition Corp
Oncorus Inc
Dyne Therapeutics Inc
MPM BioVentures 2018 LP
MPM BioVentures 2018 GP LLC
MPM BioVentures 2018 LLC
Radius Health Inc
Kailian Vaughn M
MPM BioVentures IV LLC
MPM Bio IV NVS Strategic Fund LP
MPM BioVentures IV GP LLC
Scopa James Paul
MPM Asset Management Investors BV4 LLC
Syndax Pharmaceuticals Inc
MPM BioVentures IV Strategic Fund LP
MPM BioVentures IV QP LP
MPM BioVentures IV GmbH & Co Beteiligungs KG
MPM BioVentures V LP
MPM BioVentures V GP LLC
Avalo Therapeutics Inc
MPM BioVentures V LLC
MPM Asset Management Investors BV5 LLC
TriVascular Technologies Inc
Aratana Therapeutics Inc
Epizyme Inc
Celladon Corp
Histogen Inc
Vander Vort John
Pacira BioSciences Inc
EPIRUS Biopharmaceuticals Inc
Verastem Inc
St Peter Steven
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Aktis Oncology Inc AKTS
Series A Redeemable Convertible Preferred Stock · derivative
2026-01-12 Conversion 10,227,273 $0.00
Aktis Oncology Inc AKTS
Series B Redeemable Convertible Preferred Stock · derivative
2026-01-12 Conversion 2,727,273 $0.00
Aktis Oncology Inc AKTS
Series Seed Redeemable Convertible Preferred Stock · derivative
2026-01-12 Conversion 2,272,727 $0.00
Aktis Oncology Inc AKTS
Common Stock
2026-01-12 Conversion 716,872
Aktis Oncology Inc AKTS
Common Stock
2026-01-12 Conversion 597,391
Aktis Oncology Inc AKTS
Common Stock
2026-01-12 Conversion 2,688,270
Aktis Oncology Inc AKTS
Common Stock
2026-01-12 Buy 232,870 $18.00 4,191,660
iTeos Therapeutics Inc ITOS
Common Stock
2025-05-13 Sell 630,191 $8.06 5,079,339
Werewolf Therapeutics Inc HOWL
Warrant (Right to Buy) · derivative
2025-03-27 Option exercise 18,743 $0.00
Werewolf Therapeutics Inc HOWL
Warrant (Right to Buy) · derivative
2025-03-27 Option exercise 4,015 $0.00
Werewolf Therapeutics Inc HOWL
Common Stock
2025-03-27 Sell 1,963 $1.05 2,061
Werewolf Therapeutics Inc HOWL
Common Stock
2025-03-27 Option exercise 22,758 $0.09 2,048
Entrada Therapeutics Inc TRDA
Common Stock
2024-12-11 Sell 21,787 $20.23 440,751
Entrada Therapeutics Inc TRDA
Common Stock
2024-12-10 Sell 22,935 $20.77 476,360
Repare Therapeutics Inc RPTX
Stock Option (right to buy) · derivative
2023-06-08 Grant 27,200 $0.00
TCR2 Therapeutics Inc TCRR
Common Stock
2023-06-01 Other 4,158,964 $0.00
Entrada Therapeutics Inc TRDA
Stock Option (Right to Buy) · derivative
2022-06-02 Grant 11,918 $0.00
Repare Therapeutics Inc RPTX
Stock Option (right to buy) · derivative
2022-05-13 Grant 49,000 $0.00
iTeos Therapeutics Inc ITOS
Common Stock
2022-01-05 Sell 18,135 $42.03 762,214
iTeos Therapeutics Inc ITOS
Common Stock
2022-01-04 Sell 6,768 $45.32 306,726
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com